Literature DB >> 3005631

Biosynthesis of adenovirus type 2 i-leader protein.

J S Symington, L A Lucher, K H Brackmann, A Virtanen, U Pettersson, M Green.   

Abstract

The i-leader is a 440-base-pair sequence located between 21.8 and 23.0 map units on the adenovirus type 2 genome and is spliced between the second and third segments of the major tripartite leader in certain viral mRNA molecules. The i-leader contains an open translational reading frame for a hypothetical protein of Mr about 16,600, and a 16,000-Mr polypeptide (16K protein) has been translated in vitro on mRNA selected with DNA containing the i-leader (A. Virtanen, P. Aleström, H. Persson, M. G. Katze, and U. Pettersson, Nucleic Acids Res. 10:2539-2548, 1982). To determine whether the i-leader protein is synthesized during productive infection and to provide an immunological reagent to study the properties and functions of the i-leader protein, we prepared antipeptide antibodies directed to a 16-amino acid synthetic peptide which is encoded near the N terminus of the hypothetical i-leader protein and contains a high acidic amino acid and proline content. Antipeptide antibodies immunoprecipitated from extracts of adenovirus type 2-infected cells a major 16K protein that comigrated with a 16K protein translated in vitro. Partial N-terminal amino acid sequence analysis by Edman degradation of radiolabeled 16K antigen showed that methionine is present at residue 1 and leucine is present at residues 8 and 10, as predicted from the DNA sequence, establishing that the 16K protein precipitated by this antibody is indeed the i-leader protein. Thus, the i-leader protein is a prominent species that is synthesized during productive infection. The i-leader protein is often seen as a doublet on polyacrylamide gels, suggesting that either two related forms of i-leader protein are synthesized in infected cells or that a posttranslational modification occurs. Time course studies using immunoprecipitation analysis with antipeptide antibodies revealed that the E1A 289R T antigen and the E1B-19K (175R) T antigen are synthesized beginning at 2 to 3 and 4 to 5 h postinfection, respectively, whereas the i-leader protein is synthesized starting at about 8 h postinfection and continues unabated until at least 25 h postinfection. The i-leader protein is very stable, as determined by pulse-chase labeling experiments, and accumulates continuously from 8 to 25 h postinfection, as shown by immunoblot analysis. The synthesis of i-leader protein does not depend upon viral DNA replication. Thus, the i-leader protein is a viral gene product of unknown function and high stability that is made in large quantities at intermediate times of productive infection.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3005631      PMCID: PMC252814     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Studies on the biosynthesis of viral DNA.

Authors:  M GREEN
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1962

2.  Structure of a large segment of the genome of simian virus 40 that does not encode known proteins.

Authors:  R Dhar; K N Subramanian; J Pan; S M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

3.  Complex splicing patterns of RNAs from the early regions of adenovirus-2.

Authors:  L T Chow; T R Broker; J B Lewis
Journal:  J Mol Biol       Date:  1979-10-25       Impact factor: 5.469

4.  Structure of two spliced mRNAs from the transforming region of human subgroup C adenoviruses.

Authors:  M Perricaudet; G Akusjärvi; A Virtanen; U Pettersson
Journal:  Nature       Date:  1979-10-25       Impact factor: 49.962

5.  Identification of the SV40 agnogene product: a DNA binding protein.

Authors:  G Jay; S Nomura; C W Anderson; G Khoury
Journal:  Nature       Date:  1981-05-28       Impact factor: 49.962

6.  RNA transcription and splicing at early and intermediate times after adenovirus-2 infection.

Authors:  L T Chow; J B Lewis; T R Broker
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1980

7.  Human adenoviruses: growth, purification, and transfection assay.

Authors:  M Green; W S Wold
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

8.  Identification of families of overlapping polypeptides coded by early "transforming" gene region 1 of human adenovirus type 2.

Authors:  M Green; W S Wold; K H Brackmann; M A Cartas
Journal:  Virology       Date:  1979-09       Impact factor: 3.616

9.  Control of adenovirus early gene expression: a class of immediate early products.

Authors:  J B Lewis; M B Mathews
Journal:  Cell       Date:  1980-08       Impact factor: 41.582

10.  An adenovirus agnogene.

Authors:  A Virtanen; P Aleström; H Persson; M G Katze; U Pettersson
Journal:  Nucleic Acids Res       Date:  1982-04-24       Impact factor: 16.971

View more
  15 in total

1.  Identification of a previously unrecognized promoter that drives expression of the UXP transcription unit in the human adenovirus type 5 genome.

Authors:  Baoling Ying; Ann E Tollefson; William S M Wold
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

2.  Genetic identification of adenovirus type 5 genes that influence viral spread.

Authors:  T Subramanian; S Vijayalingam; G Chinnadurai
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Adenovirus serotype 5 L4-22K and L4-33K proteins have distinct functions in regulating late gene expression.

Authors:  Susan J Morris; Keith N Leppard
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

4.  The adenovirus type 5 i-leader open reading frame functions in cis to reduce the half-life of L1 mRNAs.

Authors:  P D Soloway; T Shenk
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

5.  Adenovirus i-leader truncation bioselected against cancer-associated fibroblasts to overcome tumor stromal barriers.

Authors:  Cristina Puig-Saus; Alena Gros; Ramon Alemany; Manel Cascalló
Journal:  Mol Ther       Date:  2011-08-23       Impact factor: 11.454

6.  Human adenovirus encodes two proteins which have opposite effects on accumulation of alternatively spliced mRNAs.

Authors:  K Nordqvist; K Ohman; G Akusjärvi
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

7.  Adenovirus early region 1A modulation of interferon antiviral activity.

Authors:  K P Anderson; E H Fennie
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

8.  Molecular cloning and characterization of a cellular protein that interacts with the human immunodeficiency virus type 1 Tat transactivator and encodes a strong transcriptional activation domain.

Authors:  L Yu; Z Zhang; P M Loewenstein; K Desai; Q Tang; D Mao; J S Symington; M Green
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

9.  Abnormal expression of a late gene family L1 protein in monkey cells abortively infected with adenovirus type 2.

Authors:  C W Anderson; M M Hardy; J B Lewis
Journal:  Virus Genes       Date:  1988-03       Impact factor: 2.332

10.  Developing novel oncolytic adenoviruses through bioselection.

Authors:  Wen Yan; Galila Kitzes; Farid Dormishian; Lynda Hawkins; Adam Sampson-Johannes; Josh Watanabe; Jenny Holt; Vivian Lee; Thomas Dubensky; Ali Fattaey; Terry Hermiston; Allan Balmain; Yuqiao Shen
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.